Logo image of CVKD

CADRENAL THERAPEUTICS INC (CVKD) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:CVKD - US1276362076 - Common Stock

9.92 USD
-0.12 (-1.2%)
Last: 11/25/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
CVKD revenue by date.CVKD revenue by date.
N/AN/AN/AN/AN/A
EBITDA
YoY % growth
CVKD ebitda by date.CVKD ebitda by date.
N/A-2.7M-7.631M
-182.62%		-10.959M
-43.61%		N/A
-58.23%		N/A
-22.94%		N/A
-44.50%		N/A
-22.85%		N/A
EBIT
YoY % growth
CVKD ebit by date.CVKD ebit by date.
-2.7M-7.633M
-182.70%		-10.961M
-43.60%		N/A
-32.61%		N/A
-11.93%		N/A
-29.15%		N/A
-80.10%		N/A
347.61%
Operating Margin
CVKD operating margin by date.CVKD operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CVKD eps by date.CVKD eps by date.
N/AN/AN/A-8.67
6.34%		N/A
17.06%		N/A
52.13%		N/A
-10.22%		N/A
15.59%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-1.41
48.50%		-1.36
35.09%		-1.42
24.18%		-1.54
-17.57%		-1.26
10.36%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-4.794M
-12.10%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-3.57M
16.56%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 -1.31
39.91%		-1.560.2515.87%
Q2 2025
Q2Q % growth		 -1.87
16.89%		-1.63-0.24-14.82%
Q1 2025
Q2Q % growth		 -2.09
-39.33%		-1.67-0.42-24.94%
Q4 2024
Q2Q % growth		 -2.74
-265.33%		-1.75-0.99-56.79%
Q3 2024
Q2Q % growth		 -2.18 -1.97-0.21-10.93%
Q2 2024
Q2Q % growth		 -2.25 -1.30-0.95-73.01%
Q1 2024
Q2Q % growth		 -1.50 -1.07-0.43-40.06%
Q4 2023
Q2Q % growth		 -0.75 -1.300.5542.33%
CVKD Yearly EPS VS EstimatesCVKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 -2 -4 -6 -8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
CVKD Yearly Revenue VS EstimatesCVKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS13% 11.51% 0% -3.52%
RevenueN/A N/A N/A N/A